Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
62 /100
HIGH RISK
Score updated Aug 28, 2026

BEAT — HeartBeam, Inc. Dilution Risk Tracker

Track BEAT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BEAT — Get alerts when the score changes →

As of August 28, 2026, HeartBeam, Inc. (BEAT) has a DilutionWatch DilutionScore of 62/100, rated HIGH dilution risk. HeartBeam, Inc. has a market capitalization of $48.57M, 56.35M shares outstanding, 38 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $100.00M, ATM program capacity of $10.00M, 1.67M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
65
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 40%
💰 Capital Raise model 53%
• Under 12 months cash (7mo)
• Active shelf registration ($100M, 206% of market cap)
🔄 Reverse Split model est. 40%
• 50-day avg $1.00 approaching $1 threshold
• 7 months cash with weak price
📉 Score Deterioration model 10%
• Score in HIGH risk zone (62/100)
🔔 Track BEAT — Get forecast alerts →

Market Data

Market Cap$48.57M
Shares Outstanding56.35M
Float47.17M
Cash$8.72M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 41.9% shares (2026Q1 vs prior)
38 institutional holders · 6.47M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.40M shares
#2 BlackRock, Inc. 898.3K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 377.2K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.84M
Days to Cover4.6
% of Float3.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-09-30
xbrl XBRL CONVERTIBLE 2023-12-31
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BEAT Dilution Snapshot

HeartBeam, Inc. (BEAT) has a DilutionScore of 62/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BEAT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BEAT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BEAT
BEAT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.